Xylometazoline 0.01% w/v


WHO GMP
Certified

15 Days Easy
Returns

Long Expiry
(>8 Months)

WHO GMP
Certified

15 Days Easy
Returns

Long Expiry
(>8 Months)
In Nasal congestion (blocked nose) Naso Wikoryl 0.01% Nasal Drops shrinks the blood vessels and provides rapid relief from nasal congestion that lasts for several hours. It is a safe medicine that can be used to treat congestion caused by colds or allergies such as hay fever. It should be used as prescribed and should not be taken for more than seven days in a row (preferably less). Talk to your doctor if your symptoms do not improve.
The majority of side effects typically do not necessitate medical intervention. and disappear as your body adjusts to the medicine. Doctor consultation is advised if they persist or if you're worried about them.
Use it in the dose and duration as advised by your doctor. Check the label for directions before use. Tilt your head as far back as possible and hold the dropper close to the nose without touching it. Gently squeeze the dropper and place the medicine in the nose. Bend your head forward for a few minutes.
Naso Wikoryl 0.01% Nasal Drops is a nasal decongestant. It works by narrowing the small blood vessels in the inner surface of the nose. This provides temporary relief from congestion or stuffiness in the nose.
Seek medical advice from your doctor: Naso Wikoryl 0.01% Nasal Drops may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Doctor consultation is advised.
Safe when prescribed by an expert: Naso Wikoryl 0.01% Nasal Drops is probably safe to use during breastfeeding. Limited human data suggests that the drug does not represent any significant risk to the baby.
If you forget a dose of Naso Wikoryl 0.01% Nasal Drops , simply continue with your regular schedule and do not take a double dose.
Alembic Road, Vadodara - 390 003, Gujarat,INDIA
Biaggioni I, Robertson D. Adrenoreceptor Agonists & Sympathomimetic Drugs. In: Katzung BG, Masters SB, Trevor AJ, editors. Basic and Clinical Pharmacology. 11th ed. New Delhi, India: Tata McGraw Hill Education Private Limited; 2009. p. 140
Xylometazoline hydrochloride. Maidenhead, Berks: McNeil Products Ltd.; 1999 (23 Jan. 2019)
Xylometazoline. Brentford Middlesex: GlaxoSmithKline Consumer Healthcare; 1997 (01 Apr. 2019)
Drugs.com. Xylometazoline (01 Apr. 2019)
Central Drugs Standard Control Organisation (CDSCO) (01 Apr. 2019)
PlatinumRx is dedicated to delivering dependable and trustworthy information to empower our customers. However, the information presented here is solely for general informational purposes and should not be utilized for diagnosing, preventing, or treating health issues. It is not intended to establish a doctor-patient relationship or serve as a substitute for professional medical advice.
Flat Rs 100 on first app order | Use Code: APP100 |
Flat Rs 100 on first app order
USE CODE: APP100

Download Now